Roka Bioscience Completes IPO

The IPO is estimated to have raised $60 million before the underwriters’ option. However, the IPO pricing was below the company’s estimate of $14–$16 per share. The company has an estimated market capitalization of $217 million.

Warren, NJ 7/17/14—Roka Bioscience, a provider of testing solutions for detecting foodborne pathogens, has completed its IPO (see IBO 5/31/14, 7/15/14), offering five million shares at a price of $12.00 per share. Shares began trading on the NASDAQ Global Market on July 17 under the ticker symbol “ROKA.” The company has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares of common stock at the IPO price.

< | >